Closing comments on A.P. Pharma:
During my last post I covered a majority of the information I wanted to cover on A.P. Pharma’s anti-emetic drug, APF-530. Now I would like to conclude my analysis and present my thesis for investing in APPA.
Here are the key reasons for investing in APPA:
1.) The active compound in APF-530 (granesitron) has a [...]